Journal article Open Access

Investigation of Cross Neutralization of Egyptian Variant 2 among both Classic and Variant Vaccinal Infectious Bronchitis Viruses

Ekram S. Mahmoud; Nermeen M. El-Sayed; Ghada M. El-Sadek; Hayam F. Sayed; Lamiaa M. Omar; Mansour H. Abdel Baky


DCAT Export

<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:cnt="http://www.w3.org/2011/content#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
  <rdf:Description rdf:about="https://doi.org/10.5281/zenodo.1162904">
    <rdf:type rdf:resource="http://www.w3.org/ns/dcat#Dataset"/>
    <dct:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.5281/zenodo.1162904</dct:identifier>
    <foaf:page rdf:resource="https://doi.org/10.5281/zenodo.1162904"/>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Ekram S. Mahmoud</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Central Laboratory for Evaluation of Veterinary Biologics, Abbasia, Cairo</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Nermeen M. El-Sayed</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Central Laboratory for Evaluation of Veterinary Biologics, Abbasia, Cairo</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Ghada M. El-Sadek</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Central Laboratory for Evaluation of Veterinary Biologics, Abbasia, Cairo</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Hayam F. Sayed</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Central Laboratory for Evaluation of Veterinary Biologics, Abbasia, Cairo</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Lamiaa M. Omar</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Central Laboratory for Evaluation of Veterinary Biologics, Abbasia, Cairo</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Mansour H. Abdel Baky</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Central Laboratory for Evaluation of Veterinary Biologics, Abbasia, Cairo</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:title>Investigation of Cross Neutralization of Egyptian Variant 2 among both Classic and Variant Vaccinal Infectious Bronchitis Viruses</dct:title>
    <dct:publisher>
      <foaf:Agent>
        <foaf:name>Zenodo</foaf:name>
      </foaf:Agent>
    </dct:publisher>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2018</dct:issued>
    <dcat:keyword>Infectious Bronchitis</dcat:keyword>
    <dcat:keyword>Classic</dcat:keyword>
    <dcat:keyword>Egyptian Variant 2</dcat:keyword>
    <dcat:keyword>Cross Neutralization</dcat:keyword>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2018-01-30</dct:issued>
    <owl:sameAs rdf:resource="https://zenodo.org/record/1162904"/>
    <adms:identifier>
      <adms:Identifier>
        <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/1162904</skos:notation>
      </adms:Identifier>
    </adms:identifier>
    <dct:isVersionOf rdf:resource="https://doi.org/10.5281/zenodo.1162903"/>
    <dct:description>&lt;p&gt;Infectious Bronchitis Virus (IBV) is considered an important virus which may cause major losses in the poultry industry. One of the most important and effective tool that control the infection spread is the vaccination strategy. The present study was undertaken to determine the antigenic relationship between the currently used IBVs, classic and variant vaccinal strains, and the dominating Egyptian variant-2, IBV which could be relatively reflecting the quality of such vaccine. The recommended doses of the monovalent live IBV vaccines of Ma5, H120, 4/91 &amp;amp; CR88, and bivalent vaccine of H120-D274 were administrated via the eye-drop route in groups of 2-week-old SPF-chickens. Three weeks after vaccination, immunized and control chickens were bled, and serum samples were collected. Sera were tested individually for measuring the IBV-Haemagglutination Inhibiting (HI) antibodies against each of IBV-haemagglutinating antigen prepared from the reference classic M41 strain and the Egyptian variant.2 strain (Egy/12/2b spike protein), and IBV- neutralizing antibodies against the Egyptian variant-2 strain. The chicken groups vaccinated with the commercial live vaccines of strains Ma5, H120, 4/91, CR88 and H120-D274 of IBV respectively developed mean serum HI-antibody titers of 6.8, 6.5, 4.9, 5.0 and 5.5 log&lt;sub&gt;2&lt;/sub&gt; with the reference classic strain M41-HA antigen, and 3.0, 3.0, 4.4, 4.0, and 4.6 log&lt;sub&gt;2 &lt;/sub&gt;with the Egyptian variant.2 strain-HA antigen. However, the obtained results revealed utility of VN test more than HI test for assessment of the antigenic relatedness between the vaccinal and challenge strains of IBV as well as testing quality of different commercial live IBV vaccines using the sera of vaccinated chickens against the field strain(s) matched with the homologous strain(s); the&amp;nbsp; antigenic relatedness (r&lt;sub&gt;1 &lt;/sub&gt;) between the dominating Egyptian variant-2 strain, and the vaccinal strains, CR88, D274-H120 and H120 of IBV were 33%, 55% and 17% respectively.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/p&gt;</dct:description>
    <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
    <dct:accessRights>
      <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
        <rdfs:label>Open Access</rdfs:label>
      </dct:RightsStatement>
    </dct:accessRights>
    <dcat:distribution>
      <dcat:Distribution>
        <dct:license rdf:resource="http://creativecommons.org/licenses/by/4.0/legalcode"/>
        <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.1162904"/>
      </dcat:Distribution>
    </dcat:distribution>
  </rdf:Description>
</rdf:RDF>
12
44
views
downloads
All versions This version
Views 1212
Downloads 4444
Data volume 10.2 MB10.2 MB
Unique views 1111
Unique downloads 4444

Share

Cite as